Robertas Adomaitis



Objective of the study – to examine participation of Lithuanian men in early prostate cancer diagnosis program with regard to their age, as age is known to be an important indicator predicting the likelihood of men to suffer from prostate cancer and the opportunity to benefit from the early detection and treatment.
Data for the years 2006-2010 was analyzed: males 50-75 years old, visits to General practitioners (GPs) and the use of LPCEDP services. Odds ratios for two subgroups of men were calculated in view of Lithuanian estimated 70-year-olds life expectancy: born in 1941 and younger (“50 +”), and born in 1942 and older (“70 +”).
In 2006-2010 522717 men were identified who were eligible for LPCEDP PSA test. The “50 +” subgroup accounted for 76.6% of LPCEDP population. Within five years 20.3% of men have never been to GP, and have no possibility to participate in LPCEDP. 84.4% of GP non-attendees fall into the “50 +” subgroup. Among men alive at the end of 2010 LPCEDP penetration reached 49.8%. In calculations subgroup “70 +” was considered to be a reference. For man from the “50 +” subgroup to check PSA level in LPCEDP estimated Odds ratio was OR 0.787 (95% CI 0.775 to 0.798). For man from “70 +” subgroup to be checked more than once estimated OR 1.209 (95% CI 1.191 to 1.228), and to be checked three or more times OR 1.386 (95%CI 1.355 to 1.417).
It was found that in “70 +” subgroup males significantly more often use the PSA check in LPCEDP. Such trends in LPCEDP services in future may have a significant impact on possibility to achieve improvement in survival characteristics of prostate cancer patients.

Keyword(s): Prostate cancer, PSA, early diagnosis, LPCEDP, age group.
DOI: 10.5200/19
Full TextPDF